Analyzing Data Trends Over Time in Suppl. Figure 2

Mar 01, 2025

10 likes | 97 Vues

Explore the data trends presented in Suppl. Figure 2 to gain insights and understanding of the research findings. Analyze the visual representations and extract valuable information for further analysis and interpretation.

Share Presentation

Embed Code

Link

data trends
analysis
insights
research findings

marijke-nika

Télécharger la présentation

Analyzing Data Trends Over Time in Suppl. Figure 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Suppl. Figure 2

Suppl Figure 1.

Suppl Figure 1. . Supplementary figure S1: Dose-response curves BL: baseline measurement; H/N: measurement after randomisation to hypoxia or normoxia . Open symbols represent normoxic rats, closed symbols are hypoxic rats.

189 views • 6 slides

Suppl. Figure 1

Suppl. Figure 1. ( ng /ml). IL-6 in cell supernatant. IL-6 in animal serum. *. *. *. *. CV IL6SV CV IL6SV. CV IL6SV CV IL6SV. TRAMP-C1. TRAMP-HR. TRAMP-HR. TRAMP-C1. Suppl. Figure 2. IHC CD31. IHC Ki-67. TRAMP-C1. TRAMP-HR.

172 views • 2 slides

Suppl. Figure 4

A. DMSO. DMH1. 10 4. 14% of CD56 hi. 7% of CD56 hi. 10 3. CD56. 10 2. 7 % of CD56 Int. 3% of CD56 Int. 10 1. 0. 0. 10 1. 10 2. 10 3. 10 4. IFN- . B. IL-2. 20 ng /ml. 5 0 ng /ml. Only. + 20  M DMH1. 0. 10 1. 10 2. 10 3. 10 4. CFSE. C. IL-15.

104 views • 1 slides

Suppl. Figure 3

A. NKG2D. IL-2 + IL-12 +/- Dorsomorphin (  M). 100. 80. 60. % Max. 0. 1. 40. 20. 2. 5. 0. 10 0. 10 1. 10 2. 10 3. 10 4. 100. DMSO C ontrol. 80. 60. % Max. 40. 20. 0. 10 0. 10 1. 10 2. 10 3. 10 4. B. IL-2 + IL-12. + DMSO. (  M). + Dorsomorphin.

159 views • 1 slides

SUPPL FIGURE 1

SUPPL FIGURE 1. SUPPL FIGURE 2. A. B. --. Cal-A. LY294002. SUPPL FIGURE 3. CGP. CGP + ZNT. CGP + ZNT + ROL. A. B. SUPPL FIGURE 4. A. B. EXT. CAVEOLA. CAVEOLA. INT. G α s. G α s. G α i. G α s. . . β 2. β 2. β 2. β 2. P. P. P. P. AC. AC. AC. AC. . P. I-1.

189 views • 4 slides

Suppl. Figure 1

Suppl. Figure 1.

122 views • 1 slides

Suppl . Figure 1

Suppl . Figure 1. A. B.

126 views • 1 slides

Suppl Figure 4

500. 500. 500. 500. 400. 400. 400. 400. 300. 300. 300. 300. 200. 200. 200. 200. 100. 100. 100. 100. 0. 0. 0. 0. 0. 0. 0. 0. 200. 200. 200. 200. 400. 400. 400. 400. 600. 600. 600. 600. 800. 800. 800. 800. 500. 400. 300. 200. 100. 0. a. b. 20.

118 views • 1 slides

Suppl Figure 1

Suppl Figure 1. Growth characteristics of CHO-K1 wt and CKiD cells:

193 views • 3 slides

Suppl Figure 1

250. 200. 150. 100. 50. 0. Th0. Th1. Th2. Liver. Th17-2. Th17-1. Th17-3. Tbet. 400. GATA3. 300. 200. 400. 100. 300. 0. 200. 100. 0. Suppl Figure 1. a. b. c. AhR. FoxP3. AhR. 1000. 15. mRNA level to HPRT (x10 -3 ). mRNA level to HPRT (x10 -3 ).

136 views • 1 slides

Suppl. figure 2

Suppl. figure 2. A. B. C. D. E. F. G. H. I. J. K. L.

119 views • 1 slides

Suppl Figure 2

IL-22. 20. 18. 100. 16. 90. 14. 80. 12. 70. 10. 60. 8. 50. 6. 40. 4. 30. 2. 20. 0. 10. 0. a. IL-22. IL-17A. IL-17F. mRNA level to HPRT (x10 -3 ). 200. 20000. 70000. 150. 15000. 50000. 100. 10000. 30000. 50. 5000. 10000. 0. 0. 0. 0. 1. 1. 100. 100.

140 views • 1 slides

Suppl. Figure 3

25. 20. 15. Ellipticity (mdeg). 10. 5. 0. -5. -10. 200. 210. 220. 230. 240. Wavelength (nm). Suppl. Figure 3.

133 views • 1 slides

Suppl. Figure 1:

Suppl. Figure 1:. A. B. 31.9%.

98 views • 1 slides

Suppl. Figure 4

WT. ap2c1. AP2C1-oe. Suppl. Figure 4: Effect of AP2C1 on disease resistance Representative pictures show necroses on leaves of WT, ap2c1 and AP2C1-oe plants (line #640.2) infected with B. cinerea mycelium applied on agar plugs 4 days post inoculation. Suppl. Figure 4.

102 views • 1 slides

Suppl. Figure 2

Infect TIVE with BCBL-1 virus. TIVE KSHV + day 7 Ad-orf50 day 4. SLK KSHV + Ad-orf50. TIVE KSHV + day 7. TIVE KSHV -. 4 days post Inf. LANA IFA. K8.1. Induce lytic cycle TPA 6 days. Purify virus from TIVE; infect fresh TIVE cells. LANA IFA 4 days post Inf. Repeat 3 times.

129 views • 1 slides

Suppl Figure 5

Suppl Figure 5. WT ctl1. WT ctl1. conditional defect. NO 3 - , Cl - , sucrose Hermans et al . (2010). Low, moderate NO 3 -. High NO 3 -. Endogenous content/production ABA ↓ C K ↑ C 2 H 4 ↑↑ Exogenous supply ABA induces the arm phenotype

160 views • 1 slides

Suppl. Figure 1

Suppl. Figure 1. A. C. B. SLD. SPD. RLD. RPD. 5988. 1694. 94. 387. 64. 194.

135 views • 1 slides

Suppl. Figure 2

A. Isotype. 48 hr. 0 hr. CD56 Hi MFI:45. CD56 Hi MFI:20. CD56 High MFI:6. CD56. CD56 Int MFI:36. CD56 Int MFI:18. CD56 Int MFI:5. Intracellular BMPR1A. IL-2 + IL- 12 + Poly I:C. B. Isotype. IL-2. 10 4. CD56 Hi MFI:181. CD56 Hi MFI:19. CD56 Hii MFI:5. 10 4. 10 3.

140 views • 1 slides

Suppl. Figure 4

Suppl. Figure 4. K562. OSPC-2. 37.5 %. a). OSPC-2. K562. 1.45 %. FL4-H: scFvH6-Alexa647. FL4-H: scFvH6-Alexa647. b). A10-CLIP. A10-HALO.

160 views • 1 slides

Suppl. Figure 3

Suppl. Figure 3.

91 views • 1 slides

Suppl Figure 5

Suppl Figure 5. MB947. MB1337. MB1547. Immunoblot of Effector Proteins in Tumors from PDTX Mice Treated with TAK-733. TAK-733. vehicle. S6. vehicle. vehicle. TAK-733. TAK-733. pS6. AKT. pAKT. ERK. pERK 1/2. α-tubulin. S. TGI Response. R. S. WT. BRAF Status. V600E. V600E.

126 views • 1 slides

More Related